Annual Total Liabilities
$3.26 M
-$2.40 M-42.41%
September 30, 2024
Summary
- As of February 6, 2025, SONN annual total liabilities is $3.26 million, with the most recent change of -$2.40 million (-42.41%) on September 30, 2024.
- During the last 3 years, SONN annual total liabilities has fallen by -$3.48 million (-51.64%).
- SONN annual total liabilities is now -61.08% below its all-time high of $8.37 million, reached on September 30, 2022.
Performance
SONN Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$3.26 M
+$78.10 K+2.46%
September 30, 2024
Summary
- As of February 6, 2025, SONN quarterly total liabilities is $3.26 million, with the most recent change of +$78.10 thousand (+2.46%) on September 30, 2024.
- Over the past year, SONN quarterly total liabilities has increased by +$78.10 thousand (+2.46%).
- SONN quarterly total liabilities is now -90.50% below its all-time high of $34.27 million, reached on March 31, 2020.
Performance
SONN Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
SONN Total Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -42.4% | +2.5% |
3 y3 years | -51.6% | +2.5% |
5 y5 years | +12.9% | +2.5% |
SONN Total Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -61.1% | at low | -61.6% | +17.8% |
5 y | 5-year | -61.1% | +12.9% | -90.5% | +17.8% |
alltime | all time | -61.1% | +12.9% | -90.5% | +17.8% |
Sonnet BioTherapeutics Holdings Total Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | $3.26 M(-42.4%) | $3.26 M(+2.5%) |
Jun 2024 | - | $3.18 M(+11.3%) |
Mar 2024 | - | $2.86 M(+3.2%) |
Dec 2023 | - | $2.77 M(-51.1%) |
Sep 2023 | $5.66 M(-32.4%) | $5.66 M(-14.5%) |
Jun 2023 | - | $6.62 M(-16.7%) |
Mar 2023 | - | $7.94 M(-6.3%) |
Dec 2022 | - | $8.48 M(+1.3%) |
Sep 2022 | $8.37 M | $8.37 M(+24.4%) |
Jun 2022 | - | $6.73 M(+3.3%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | $6.51 M(+49.7%) |
Dec 2021 | - | $4.35 M(-35.4%) |
Sep 2021 | $6.73 M(+35.4%) | $6.73 M(+16.0%) |
Jun 2021 | - | $5.81 M(+3.6%) |
Mar 2021 | - | $5.60 M(+1.5%) |
Dec 2020 | - | $5.52 M(+11.0%) |
Sep 2020 | $4.97 M(+72.4%) | $4.97 M(+42.1%) |
Jun 2020 | - | $3.50 M(-89.8%) |
Mar 2020 | - | $34.27 M |
Sep 2019 | $2.89 M | - |
FAQ
- What is Sonnet BioTherapeutics Holdings annual total liabilities?
- What is the all time high annual total liabilities for Sonnet BioTherapeutics Holdings?
- What is Sonnet BioTherapeutics Holdings annual total liabilities year-on-year change?
- What is Sonnet BioTherapeutics Holdings quarterly total liabilities?
- What is the all time high quarterly total liabilities for Sonnet BioTherapeutics Holdings?
- What is Sonnet BioTherapeutics Holdings quarterly total liabilities year-on-year change?
What is Sonnet BioTherapeutics Holdings annual total liabilities?
The current annual total liabilities of SONN is $3.26 M
What is the all time high annual total liabilities for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high annual total liabilities is $8.37 M
What is Sonnet BioTherapeutics Holdings annual total liabilities year-on-year change?
Over the past year, SONN annual total liabilities has changed by -$2.40 M (-42.41%)
What is Sonnet BioTherapeutics Holdings quarterly total liabilities?
The current quarterly total liabilities of SONN is $3.26 M
What is the all time high quarterly total liabilities for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high quarterly total liabilities is $34.27 M
What is Sonnet BioTherapeutics Holdings quarterly total liabilities year-on-year change?
Over the past year, SONN quarterly total liabilities has changed by +$78.10 K (+2.46%)